Medpage Today on MSN1 天
Year in Review: Multiple Myeloma
One of the major stories in multiple myeloma in 2024 was the comeback of belantamab mafodotin (Blenrep) after it had been ...
Identical twins Karen Rodman and Linda Thomas have been inseparable since birth: after all these years, they work together, ...
Medically reviewed by Doru Paul, MD Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white ...
Researchers identified a six-gene pattern predicting venetoclax response in multiple myeloma. This genetic insight allows for ...
值得一提的是,9月4日,岸迈生物授予Vignette ...
Matias Sanchez, MD, assistant professor in the Department of Medicine at the University of Illinois Chicago, discussed recent advancements in multiple myeloma treatment, including the potential of ...
Researchers sought to determine whether PRD monitoring would be a suitable replacement for MRD in multiple myeloma.
A treatment approach harnessing bispecific antibodies to target cancerous cells unlocks new possibilities for patients, says ...
Cesar Rodriguez, MD, discussed several key aspects of talquetamab use in the treatment of relapsed/refractory multiple ...
Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...
Paul Mancini had his first hint that something might be wrong when he felt a sharp pain on one side of his chest in the ...